Hypothesis

Aging reduces mitochondrial ATP production at the neuromuscular junction (NMJ), lowering the frequency and amplitude of activity‑dependent calcium transients. This energy shortfall shifts the calcineurin/NFATc3 balance toward cytoplasmic retention, permitting FoxO‑driven atrogene expression and fiber loss. If the ATP deficit is corrected locally, NFATc3 remains nuclear even with diminished neural input, blocking the atrophy program and revealing sarcopenia as an energy‑sensing pruning mechanism rather than inevitable damage.

Mechanistic Rationale

• Calcium influx activates calcineurin, which dephosphorylates NFATc3, enabling nuclear translocation and transcription of pro‑myogenic genes (myogenin, MEF2A) while suppressing atrogenes ([2][3]).
• ATP is required for both the SERCA pump that refills sarcoplasmic reticulum calcium stores and the mitochondrial calcium uniporter that shapes cytosolic calcium spikes ([4]). Declining ATP reduces calcium transient amplitude, weakening calcineurin activation.
• Reduced NFATc3 nuclear residency decreases miR‑23a expression, lifting repression of atrogin‑1 and MuRF1 ([1]).
• Thus, the NMJ‑calcineurin/NFAT axis functions as a metabolic checkpoint: sufficient ATP sustains NFATc3‑mediated myogenic tone; ATP shortage flips the switch to atrophy.

Testable Predictions

1. Local ATP restoration preserves NFATc3 nuclear localization in aged mouse muscle despite reduced NMJ activity.

   • Approach: Deliver AAV‑mitochondrial‑targeted ATP synthase or administer NMJ‑targeted NAD⁺ booster (e.g., Mito‑NR) to tibialis anterior of 24‑month‑old mice; verify ATP increase via luciferase assay.
   • Readout: Immunofluorescence for NFATc3 nuclear/cytoplasmic ratio; expect ≥2‑fold increase versus saline control.

2. Preserved NFATc3 nuclear signaling blocks atrogene upregulation and fiber atrophy under denervation conditions.

   • Approach: Combine the ATP‑boosting intervention with sciatic nerve crush; measure atrogin‑1/MuRF1 mRNA (qPCR) and cross‑sectional area (histology) at 7 days post‑injury.
   • Prediction: ATP‑treated, denervated fibers will show atrogene levels comparable to innervated controls and <15% atrophy, whereas controls will exhibit >30% atrophy.

3. Artificial ATP depletion in young muscle mimics the aged phenotype by driving NFATc3 cytoplasmic shift and atrophy.

   • Approach: Treat 3‑month‑old mice with low‑dose oligomycin (mitochondrial ATP synthase inhibitor) locally via osmotic pump; assess NFATc3 localization and fiber size.
   • Prediction: Oligomycin‑treated young fibers will display NFATc3 cytoplasmic retention and atrogene induction similar to aged untreated muscle.

Falsifiability

If raising intramuscular ATP fails to increase NFATc3 nuclear retention or to protect fibers from atrophy after denervation, the hypothesis that ATP‑dependent calcineurin/NFAT signaling is the pivotal metabolic checkpoint would be refuted. Conversely, confirming the predictions would support the view that age‑related muscle loss is, at least in part, an adaptive pruning response to energetic insufficiency rather than purely pathological damage.